Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Cardiovascular disease-related mortality among US adults with myeloma remained stable over 25 years, but increases in hypertensive, arrhythmic, thromboembolic, and heart failure mortality were seen in 2018-21, coinciding with COVID-19.”
Title: Temporal trends and disparities in cardiovascular disease-related mortality among adults with multiple myeloma in the United States, 1999–2023
Authors: Ying Tian, Xiaobin Guo, Yue Zhang
You can read the Full Article in BMC Cardiovascular Disorders.
You can find more posts featuring Robert Orlowski on OncoDaily.
